These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34219710)

  • 21. A vicious circle: role of oxidative stress, intraneuronal Abeta and Cu in Alzheimer's disease.
    Bayer TA; Schäfer S; Breyhan H; Wirths O; Treiber C; Multhaup G
    Clin Neuropathol; 2006; 25(4):163-71. PubMed ID: 16866297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Redox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer's Disease.
    Kim N; Lee HJ
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Copper Toxicity Links to Pathogenesis of Alzheimer's Disease and Therapeutics Approaches.
    Ejaz HW; Wang W; Lang M
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding the Amyloid Hypothesis in Alzheimer's Disease.
    Paroni G; Bisceglia P; Seripa D
    J Alzheimers Dis; 2019; 68(2):493-510. PubMed ID: 30883346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metals and Alzheimer's disease.
    Adlard PA; Bush AI
    J Alzheimers Dis; 2006 Nov; 10(2-3):145-63. PubMed ID: 17119284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metallostasis in Alzheimer's disease.
    Ayton S; Lei P; Bush AI
    Free Radic Biol Med; 2013 Sep; 62():76-89. PubMed ID: 23142767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iron, Copper, and Zinc Concentration in Aβ Plaques in the APP/PS1 Mouse Model of Alzheimer's Disease Correlates with Metal Levels in the Surrounding Neuropil.
    James SA; Churches QI; de Jonge MD; Birchall IE; Streltsov V; McColl G; Adlard PA; Hare DJ
    ACS Chem Neurosci; 2017 Mar; 8(3):629-637. PubMed ID: 27958708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways.
    White AR; Huang X; Jobling MF; Barrow CJ; Beyreuther K; Masters CL; Bush AI; Cappai R
    J Neurochem; 2001 Mar; 76(5):1509-20. PubMed ID: 11238735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unveiling the Effects of Copper Ions in the Aggregation of Amyloidogenic Proteins.
    Oliveri V
    Molecules; 2023 Sep; 28(18):. PubMed ID: 37764220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulatory Activities of Dopamine and Its Derivatives toward Metal-Free and Metal-Induced Amyloid-β Aggregation, Oxidative Stress, and Inflammation in Alzheimer's Disease.
    Nam E; Derrick JS; Lee S; Kang J; Han J; Lee SJC; Chung SW; Lim MH
    ACS Chem Neurosci; 2018 Nov; 9(11):2655-2666. PubMed ID: 29782798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Redox reactions of copper complexes formed with different beta-amyloid peptides and their neuropathological [correction of neuropathalogical] relevance.
    Jiang D; Men L; Wang J; Zhang Y; Chickenyen S; Wang Y; Zhou F
    Biochemistry; 2007 Aug; 46(32):9270-82. PubMed ID: 17636872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural studies of the Alzheimer's amyloid precursor protein copper-binding domain reveal how it binds copper ions.
    Kong GK; Adams JJ; Harris HH; Boas JF; Curtain CC; Galatis D; Masters CL; Barnham KJ; McKinstry WJ; Cappai R; Parker MW
    J Mol Biol; 2007 Mar; 367(1):148-61. PubMed ID: 17239395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metal Ions in Alzheimer's Disease: A Key Role or Not?
    Liu Y; Nguyen M; Robert A; Meunier B
    Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of oxidative stress and other pathologies in Alzheimer's disease.
    Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
    Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metals, oxidative stress and neurodegenerative disorders.
    Jomova K; Vondrakova D; Lawson M; Valko M
    Mol Cell Biochem; 2010 Dec; 345(1-2):91-104. PubMed ID: 20730621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amyloid precursor protein processing and Alzheimer's disease.
    O'Brien RJ; Wong PC
    Annu Rev Neurosci; 2011; 34():185-204. PubMed ID: 21456963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aluminum exposure through the diet: metal levels in AbetaPP transgenic mice, a model for Alzheimer's disease.
    Gómez M; Esparza JL; Cabré M; García T; Domingo JL
    Toxicology; 2008 Jul; 249(2-3):214-9. PubMed ID: 18571827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amyloid precursor protein, copper and Alzheimer's disease.
    Multhaup G
    Biomed Pharmacother; 1997; 51(3):105-11. PubMed ID: 9181045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclooxygenase-1 inhibition reduces amyloid pathology and improves memory deficits in a mouse model of Alzheimer's disease.
    Choi SH; Aid S; Caracciolo L; Minami SS; Niikura T; Matsuoka Y; Turner RS; Mattson MP; Bosetti F
    J Neurochem; 2013 Jan; 124(1):59-68. PubMed ID: 23083210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.